Arrowhead Pharmaceuticals
ARWR
$22.61
Share price
0.36%
Change (1 day)
-25.63%
Change (1 year)
Categories
Arrowhead Pharmaceuticals (ARWR) - Total assets
Total assets on the balance sheet as of December 2023 : $0.62 B
According to Arrowhead Pharmaceuticals 's latest financial reports the company's total assets are $0.62 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Arrowhead Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-09-30 | $0.76 B | 10.64% |
| 2022-09-30 | $0.69 B | -2.56% |
| 2021-09-30 | $0.71 B | 35.91% |
| 2020-09-30 | $0.52 B | 49.35% |
| 2019-09-30 | $0.34 B | 213.45% |
| 2018-09-30 | $0.11 B | 7.29% |
| 2017-09-30 | $0.10 B | -18.84% |
| 2016-09-30 | $0.12 B | -3.09% |
| 2015-09-30 | $0.13 B | -27.65% |
| 2014-09-30 | $0.18 B | 389.74% |
| 2013-09-30 | $37.32 M | 125.86% |
| 2012-09-30 | $16.52 M | 4.02% |
| 2011-09-30 | $15.88 M | 28.61% |
| 2010-09-30 | $12.35 M | 60.4% |
| 2009-09-30 | $7.7 M | -55.36% |
| 2008-09-30 | $17.25 M | -42.2% |
| 2007-09-30 | $29.85 M | -13.53% |
| 2006-09-30 | $34.52 M | 18.89% |
| 2005-09-30 | $29.04 M | 143.72% |
| 2004-09-30 | $11.91 M | 686.03% |
| 2003-09-30 | $1.51 M | 2285.01% |
| 2002-09-30 | $0.06 M | 37.27% |
| 2001-09-30 | $0.04 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 26,654.23% | 🇺🇸 USA |
 Moderna
MRNA | $18.42 B | 2,842.11% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.78 B | 25.70% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.82 B | 511.52% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | $0.17 B | -72.70% | 🇺🇸 USA |